WHO ICTRP trial
Levofloxacin versus ciprofloxacin combined with penicillin for the prevention of…
NL-OMON21952 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON21952 |
|---|---|
| Public title | Levofloxacin versus ciprofloxacin combined with penicillin for the prevention of bacterial infections in neutropenic patients with hematological malignancies: a single center, randomized clinical trial. |
| Scientific title | Levofloxacin versus ciprofloxacin combined with penicillin for the prevention of bacterial infections in neutropenic patients with hematological malignancies: a single center, randomized clinical trial. |
| Primary sponsor | Dept. of Hematology VUmc, Amsterdam, the Netherlands |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Neutropenic patients with hematological malignancies. |
| Interventions | Conventional arm: ciprofloxacin 500mg 2x/day and feniticilline 250mg 4x/day Experimental arm: levofloxacine 500mg 1x/day. Both arms will be given from start chemotherapy until ANC recovery (>0,5x109). |
| Registration date | Sep 12, 2005 |
| Target size | 245 |
| Secondary IDs | NL303;NTR341; : N/A;ISRCTN68044984 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: